North Star Asset Management’s Eli Lilly LLY Stock Holding History

North Star Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.7M	Sell	11,581 -592	-5%	-$600K	0.46%	69
2025 Q4	$13.1M	Sell	12,173 -1,335	-10%	-$1.28M	0.53%	61
2025 Q3	$10.3M	Sell	13,508 -2,098	-13%	-$1.56M	0.42%	77
2025 Q2	$12.2M	Sell	15,606 -476	-3%	-$370K	0.51%	65
2025 Q1	$13.3M	Sell	16,082 -343	-2%	-$285K	0.61%	57
2024 Q4	$12.7M	Buy	16,425 +325	+2%	+$269K	0.56%	62
2024 Q3	$14.3M	Sell	16,100 -217	-1%	-$195K	0.64%	57
2024 Q2	$14.8M	Sell	16,317 -621	-4%	-$497K	0.7%	54
2024 Q1	$13.2M	Sell	16,938 -70	-0.4%	-$49.8K	0.62%	60
2023 Q4	$9.91M	Sell	17,008 -529	-3%	-$309K	0.51%	67
2023 Q3	$9.42M	Sell	17,537 -510	-3%	-$263K	0.54%	65
2023 Q2	$8.46M	Sell	18,047 -2,269	-11%	-$952K	0.47%	74
2023 Q1	$6.98M	Sell	20,316 -358	-2%	-$121K	0.41%	75
2022 Q4	$7.56M	Sell	20,674 -3,739	-15%	-$1.33M	0.47%	74
2022 Q3	$7.89M	Sell	24,413 -925	-4%	-$293K	0.54%	66
2022 Q2	$8.21M	Sell	25,338 -2,719	-10%	-$816K	0.54%	64
2022 Q1	$8.03M	Sell	28,057 -309	-1%	-$79.5K	0.44%	70
2021 Q4	$7.84M	Buy	28,366 +644	+2%	+$163K	0.39%	75
2021 Q3	$6.41M	Buy	27,722 +526	+2%	+$130K	0.35%	79
2021 Q2	$6.24M	Buy	27,196 +1,896	+7%	+$381K	0.35%	78
2021 Q1	$4.73M	Buy	25,300 +2,048	+9%	+$401K	0.28%	89
2020 Q4	$3.93M	Buy	23,252 +20,872	+877%	+$3.12M	0.25%	95
2020 Q3	$352K	Hold	2,380	–	–	0.03%	209
2020 Q2	$391K	Buy	2,380 +20	+0.8%	+$3.07K	0.03%	196
2020 Q1	$327K	Sell	2,360 -1,260	-35%	-$173K	0.03%	198
2019 Q4	$476K	Hold	3,620	–	–	0.03%	203
2019 Q3	$405K	Sell	3,620 -50	-1%	-$5.57K	0.03%	213
2019 Q2	$407K	Hold	3,670	–	–	0.03%	212
2019 Q1	$476K	Hold	3,670	–	–	0.04%	199
2018 Q4	$425K	Hold	3,670	–	–	0.04%	204
2018 Q3	$394K	Sell	3,670 -65	-2%	-$6.5K	0.03%	219
2018 Q2	$319K	Sell	3,735 -50	-1%	-$4.11K	0.03%	233
2018 Q1	$293K	Hold	3,785	–	–	0.03%	236
2017 Q4	$320K	Buy	3,785 +1,125	+42%	+$95.7K	0.03%	233
2017 Q3	$228K	Hold	2,660	–	–	0.02%	238
2017 Q2	$219K	Hold	2,660	–	–	0.02%	234
2017 Q1	$224K	Buy	+2,660	New	+$213K	0.02%	224
2016 Q4	–	Sell	-2,860	Closed	-$230K	–	244
2016 Q3	$230K	Hold	2,860	–	–	0.03%	217
2016 Q2	$225K	Buy	+2,860	New	+$215K	0.03%	217
2016 Q1	–	Sell	-2,660	Closed	-$224K	–	245
2015 Q4	$224K	Hold	2,660	–	–	0.03%	217
2015 Q3	$223K	Hold	2,660	–	–	0.03%	220
2015 Q2	$222K	Sell	2,660 -100	-4%	-$7.62K	0.03%	238
2015 Q1	$201K	Sell	2,760 -150	-5%	-$10.7K	0.02%	241
2014 Q4	$201K	Buy	+2,910	New	+$196K	0.02%	241

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

North Star Asset Management's LLY Position: Q1 2026 in Review

North Star Asset Management reduced its Eli Lilly (LLY) stake by 4.9% in Q1 2026, selling an estimated $600K and leaving 11,581 shares worth $10.7M. The position accounts for 0.46% of the portfolio, ranked #69.

North Star Asset Management first reported a position in LLY in Q4 2014 and has held it in 44 quarters since. The position peaked at $14.8M in Q2 2024. 4,351 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

North Star Asset Management held 11,581 shares of Eli Lilly worth $10.7M as of Q1 2026.
North Star Asset Management sold 592 Eli Lilly shares in Q1 2026, an estimated $600K.
Eli Lilly made up 0.46% of North Star Asset Management's portfolio in Q1 2026, its #69 holding.
North Star Asset Management first reported a position in Eli Lilly in Q4 2014 and has held it in 44 quarters since.
North Star Asset Management's Eli Lilly position peaked at $14.8M in Q2 2024.
4,351 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on North Star Asset Management's 13F filing for Q1 2026, filed 6 May 2026.